4
Changes in Ownership
Karyopharm Therapeutics Inc. Filed Acc 0001209191-20-049920
EVP, CBO, GC & Secretary sold 10,054 shares at $14.98 ($150,609)
- EVP, CBO, GC & Secretary acquired 10,054 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Primiano Christopher Brett · EVP, CBO, GC & Secretary
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-09-08 | Exercise or conversion : show line 1 in the form | +10,054 | $6.54 | $65,753 | 14,703 | D |
| 2020-09-08 | Sale : show line 2 in the form | −10,054 | $14.98 | $150,609 | 4,649 | D |
| Open-market sales · 10,054 sh · avg $14.98 · $150,609 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2020-09-08 | Exercise or conversion : show line 3 in the form Stock Option (right to buy) | −10,054 | $6.54 | 2026-01-14 | 10,054 | 0 | D |
Loading xslF345X03/doc4.xml…